3098 Nivolumab (NIVO) monotherapy or in combination with ipilimumab (IPI) for treatment of recurrent small cell lung cancer (SCLC)
Calvo, E., López-Martin, J.A., Bendell, J., Eder, J.P., Taylor, M., Ott, P.A., Pietanza, M.C., Horn, L., Jäger, D., Braud, F. De, Morse, M.A., Ascierto, P.A., Le, D.T., Amin, A., Evans, J., Simon, J.,Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31739-7
Date:
September, 2015
File:
PDF, 62 KB
english, 2015